,

9-Me-BC | 35mg/1,5ml

$116.00

What is 9-Me-BC?

9-Me-BC (9-methyl-β-carboline) is a compound from the beta-carboline group that is being studied intensively in the context of neuroprotection, cognitive function, and regulation of dopaminergic activity. The molecule is structurally close to natural metabolites in the brain and shows potential to influence the dopaminergic system in a selective and modulatory way, without direct stimulation.

Unlike classical psychostimulants, 9-Me-BC does not deplete dopamine; it supports its restoration and long-term stabilization. This makes it of interest for research protocols aimed at cognitive performance, motivation, concentration, and maintaining healthy neuronal function.

Mechanism of action of 9-Me-BC:

9-Me-BC acts through several parallel mechanisms. The primary effect is modulation of the dopamine system—stimulating the growth and functions of dopaminergic neurons without causing dopamine depletion. In addition, the compound exerts a neuroprotective effect by reducing oxidative stress and influencing enzymes involved in cellular recovery.

Research indicates that 9-Me-BC may increase the expression of genes related to neurotrophins and improve mitochondrial function in brain tissue. This complex, yet balanced effect on neurons positions it as a promising molecule in research related to brain function and protection.

Potential science-backed benefits of 9-Me-BC:

Laboratory analyses show a range of potential benefits from the application of 9-Me-BC in a controlled research environment:

  • Improving dopaminergic activity and receptor sensitivity;
  • Increasing concentration, motivation, and alertness;
  • Neuroprotective effect—reducing oxidative stress in the brain;
  • Stimulation of neuronal branching (dendritogenesis);
  • Possible support with mental fatigue and cognitive decline.

Thanks to these properties, 9-Me-BC is used in protocols exploring neurological recovery, maintenance of cognitive sharpness, and adaptation to mental stress.

Dosage and application of 9-Me-BC in research protocols:

Recommended research scheme: 5 units once daily (morning), for 4–6 weeks, followed by 2–4 weeks rest period.

1 unit = 23.33mcg.

Total amount in pen: 150 units

Possible side effects of 9-Me-BC:

Despite the favorable neurotropic profile of 9-Me-BC, there are observations of some side effects, especially at higher doses or sensitivity to dopaminergic changes:

  • Insomnia or nervousness, especially when taken in the late hours;
  • Headache or tension;
  • Mood changes with prolonged use.

Adhering to optimal dosing and controlling the duration of application play a key role in limiting the manifestation of side effects.

Disclaimer

For research use only. Not for human consumption.

Guaranteed Safe Checkout
Shopping Cart
error: Content is protected !!
9-Me-BC | 35mg/1,5ml9-Me-BC | 35mg/1,5ml
$116.00
Scroll to Top